Pipeline

Modality	Code	Classification	Indication	Discovery
RNA치료제 (ASO)	ATB-320	화학항암제 병용	췌장암, 담도암	Discovery Non-Clinical Phase 1 Phase 2 Phase 3 NDA 임상 1상 IND 승인
	ATB-720	면역 조절제	아토피 피부염, 건선	Discovery Non-Clinical Phase 1 Phase 2 Phase 3 NDA Discovery
	ATB-810	면역 조절제	신경퇴행 병증 (ALS, MS)	Discovery Non-Clinical Phase 1 Phase 2 Phase 3 NDA Discovery
개량신약	ATB-101	FDC	당뇨/고혈압	Discovery Non-Clinical Phase 1 Phase 2 Phase 3 NDA Phase 3